Literature DB >> 8443156

Assignment of 1H, 15N, and 13C resonances, identification of elements of secondary structure and determination of the global fold of the DNA-binding domain of GAL4.

M Shirakawa1, W J Fairbrother, Y Serikawa, T Ohkubo, Y Kyogoku, P E Wright.   

Abstract

Almost complete assignments of the 1H, 15N, and aliphatic 13C resonances of the 62-residue N-terminal DNA-binding domain of GAL4 [GAL4(62)] have been obtained using a combination of two-dimensional homonuclear and two- and three-dimensional double- and triple-resonance heteronuclear NMR methods. The sequential NOE connectivities, amide proton exchange measurements, and 13C alpha chemical shift data indicate the presence of two short alpha-helices in the N-terminal half of the polypeptide. Residues 1-9 and 41-62 appear to be unstructured and flexible in solution. Analysis of the 13C alpha chemical shifts also revealed a significant downfield shift of approximately +3 ppm, relative to random-coil values, for the four nonbridging Zn(II) ligands, Cys 14, 21, 31, and 38. Interestingly, no such correlation was observed for the two bridging ligands, Cys 11 and 28. Preliminary structure calculations using a subset of distance restraints derived from three-dimensional 1H-15N and 1H-13C NOESY-HSQC spectra are consistent with the recently reported solution structures of Zn(II)2GAL4(7-49) [Kraulis, P., et al. (1992) Nature 356, 448-450] and of Cd(II)2GAL4(65) [Baleja, J. D., et al. (1992) Nature 356, 450-453].

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8443156     DOI: 10.1021/bi00060a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Sequence-specific NMR assignment of proteins by global fragment mapping with the program MAPPER.

Authors:  P Güntert; M Salzmann; D Braun; K Wüthrich
Journal:  J Biomol NMR       Date:  2000-10       Impact factor: 2.835

2.  Refined solution structure of the DNA-binding domain of GAL4 and use of 3J(113Cd,1H) in structure determination.

Authors:  J D Baleja; V Thanabal; G Wagner
Journal:  J Biomol NMR       Date:  1997-12       Impact factor: 2.835

Review 3.  Principles of protein folding--a perspective from simple exact models.

Authors:  K A Dill; S Bromberg; K Yue; K M Fiebig; D P Yee; P D Thomas; H S Chan
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

Review 4.  Resonance assignment strategies for the analysis of NMR spectra of proteins.

Authors:  M F Leopold; J L Urbauer; A J Wand
Journal:  Mol Biotechnol       Date:  1994-08       Impact factor: 2.695

5.  1H, 15N, 13C and 13CO assignments and secondary structure determination of basic fibroblast growth factor using 3D heteronuclear NMR spectroscopy.

Authors:  F J Moy; A P Seddon; E B Campbell; P Böhlen; R Powers
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

6.  UME6, a negative regulator of meiosis in Saccharomyces cerevisiae, contains a C-terminal Zn2Cys6 binuclear cluster that binds the URS1 DNA sequence in a zinc-dependent manner.

Authors:  S F Anderson; C M Steber; R E Esposito; J E Coleman
Journal:  Protein Sci       Date:  1995-09       Impact factor: 6.725

7.  HeteroTOCSY-based experiments for measuring heteronuclear relaxation in nucleic acids and proteins.

Authors:  B I Schweitzer; K H Gardner; G Tucker-Kellogg
Journal:  J Biomol NMR       Date:  1995-09       Impact factor: 2.835

8.  113Cd-1H heteroTOCSY: a method for determining metal-protein connectivities.

Authors:  K H Gardner; J E Coleman
Journal:  J Biomol NMR       Date:  1994-11       Impact factor: 2.835

9.  The 13C chemical-shift index: a simple method for the identification of protein secondary structure using 13C chemical-shift data.

Authors:  D S Wishart; B D Sykes
Journal:  J Biomol NMR       Date:  1994-03       Impact factor: 2.835

10.  DNA binding and bending by the transcription factors GAL4(62*) and GAL4(149*).

Authors:  K K Rodgers; J E Coleman
Journal:  Protein Sci       Date:  1994-04       Impact factor: 6.725

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.